Browsing by Author Lubel, John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 ` final results of the REV1TAL studyGeorge, Jacob; Bollipo, Steven; Chivers, Sarah; Dore, Gregory J.; et al, Various; Fragomeli, Vincenzo; Gow, Paul J; Iser, David M.; Jones, Tracey L.; Levy, Miriam; Lubel, John; Mitchell, Joanne L.; Pianko, Stephen; Strasser, S; Stuart, Katherine Anne; Thompson, Alexander James V.; Westmead Clinical School: Westmead Institute for Medical ResReal-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 ` final results of the REV1TAL study, Antiviral Therapy, vol.22, 8, 2017,pp 699-710
2016Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyStrasser, Simone; Bell, Sally; Doyle, Adam; et al, Various; Gill, Raghubinder; Gow, Paul J; Hong, Thai; Lubel, John; Marsh, Philip; Mohsen, Waled; Nicoll, Amanda J.; Rodov, Marcia; Ryan, Marno; Varma, Poornima; Central Clinical School: MedicineSorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study, Scandinavian Journal of Gastroenterology, vol.51, 8, 2016,pp 979-985